세계의 바이오테크놀러지 시약 시장 보고서(2025년)
Biotechnology Reagents Global Market Report 2025
상품코드 : 1821618
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오테크놀러지 시약 시장의 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 9.9%로 1,345억 3,000만 달러로 성장할 전망입니다. 예측기간의 성장은 단일 세포 분석 기술, 합성생물학의 확대, 글리코믹스의 중요성 증가, 세포 배양 애플리케이션의 확대, 바이오 뱅킹 및 바이오 리포지토리의 성장, 건강 위기에 대한 세계적인 대응에 기인할 것으로 예상됩니다. 예측기간의 주요 동향으로는 생명공학 연구의 급속한 진전, 유동세포계측기술의 진보, 줄기세포 연구에 대한 주력, crispr-cas9 시약 수요, 커스터마이즈 시약과 특수 시약, 품질 관리와 표준화에 대한 주력 등이 있습니다.

향후 5년간의 예측 성장률 9.9%는 이 시장의 과거 예측에서 0.3% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 상승은 중국과 캐나다에서 조달하는 CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats) 효소와 차세대 시퀀서 시약의 비용을 높여 연구 비용을 악화시키고 과학적 발견 능력을 제한함으로써 미국 내 연구소에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

중합효소연쇄반응(PCR)에 대한 수요 증가는 향후 바이오테크놀러지 시약 시장의 성장을 이끌 것으로 예측됩니다. PCR은 DNA의 작은 조각을 큰 조각으로 증폭하는 데 사용되는 분자기술이며 특정 감염의 진단 및 유전적 변화 연구에 필수적입니다. 바이오테크놀러지 시약은 PCR 과정에서 안정한 pH를 유지하고 적절한 DNA 합성을 보장하는 데 매우 중요하며 나중에 다양한 유전체 연구 및 진단 목적으로 사용할 수 있습니다. 예를 들어 영국의 정부기관 Health Security Agency가 2022년 3월 발표한 보고서에 따르면 NHS의 Test and Trace 프로그램에 많은 비용이 발생하여 2021-2022 회계연도에는 157억 파운드의 지출이 발생한 것으로 나타났습니다. 이는 주로 PCR과 신속 래터럴 플로우 검사 모두에 대한 수요에 의해 발생하였습니다. 따라서 PCR에 대한 수요 증가는 바이오테크놀러지 시약 시장의 성장을 가속하는 중요한 요소입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Biotechnology reagents are chemical compounds employed in the detection, measurement, and preparation of various products by facilitating chemical reactions. These reagents play a crucial role in quantifying and detecting specific substances, with their binding to the target substances triggering specific reactions.

The primary types of biotechnology reagents include life science reagents, analytical reagents, and other reagents. Life science reagents are substances utilized in chemical reactions to observe data changes and analyze this data to understand the causes of diseases. These reagents find applications in diverse areas such as protein synthesis and purification, gene expression, DNA and RNA analysis, and drug testing. End-users of biotechnology reagents encompass biotech companies, research institutes, pharmaceuticals, diagnostic centers, academic institutes, and other entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biotechnology reagents market research report is one of a series of new reports from The Business Research Company that provides Biotechnology reagents market statistics, including Biotechnology reagents industry global market size, regional shares, competitors with a Biotechnology reagents market share, detailed Biotechnology reagents market segments, market trends and opportunities, and any further data you may need to thrive in the Biotechnology reagents industry. This Biotechnology reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology reagents market size has grown strongly in recent years. It will grow from $85.19 billion in 2024 to $92.14 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to rise in biopharmaceutical development, genomics and proteomics research expansion, drug discovery and development, increasing life sciences research funding, global focus on precision medicine.

The biotechnology reagents market size is expected to see strong growth in the next few years. It will grow to $134.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to single-cell analysis techniques, expansion of synthetic biology, rising importance of glycomics, expansion of cell culture applications, biobanking and biorepository growth, global response to health crises. Major trends in the forecast period include rapid advancements in biotechnology research, technological advances in flow cytometry, focus on stem cell research, demand for crispr-cas9 reagents, customized and specialty reagents, focus on quality control and standardization.

The forecast of 9.9% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. research labs by driving up the cost of Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) enzymes and next-generation sequencing reagents sourced from China and Canada, exacerbating research costs and limiting scientific discovery capabilities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for polymerase chain reaction (PCR) is anticipated to drive the growth of the biotechnology reagents market in the future. PCR is a molecular technique used to amplify small segments of DNA into larger ones, which are essential for diagnosing certain infectious diseases and studying genetic changes. Biotechnology reagents are crucial for maintaining a stable pH during the PCR process, ensuring proper DNA synthesis, which can later be utilized for various genomic studies and diagnostic purposes. For instance, a report published in March 2022 by the Health Security Agency, a UK government body, highlighted that the NHS Test and Trace program incurred substantial costs, with an estimated expenditure of £15.7 billion for the financial year 2021-2022, largely driven by increased demand for both PCR and rapid lateral flow tests. Therefore, the rising demand for PCR is a key factor propelling the growth of the biotechnology reagents market.

The increasing prevalence of chronic diseases is poised to drive the growth of the biotechnology reagents market. Chronic diseases require a multifaceted approach involving individual responsibility, healthcare interventions, and societal measures. Biotechnology reagents serve as essential tools for scientists, enabling them to study, diagnose, and find potential treatments for chronic diseases. A notable projection from the National Library of Medicine indicates a 99.5% increase in the number of individuals aged 50 and older with at least one chronic condition in the US by 2050, emphasizing the growing significance of biotechnology reagents.

Technological advancement emerges as a pivotal trend in the biotechnology reagent market, with major companies focusing on innovation to strengthen their market position. For instance, in April 2022, CN BIO Innovations introduced the PhysioMimix in-a-box reagent kit, leveraging Organs-on-chips systems for studying diseases like non-alcoholic steatohepatitis. This innovative approach facilitates more accurate and cost-effective drug development, reflecting the impact of technology trends on product offerings in the biotechnology reagent market.

Product innovation stands out as a driving force in the biotechnology reagent market, with major companies investing in the development of novel products. For example, in May 2023, Bio-Techne's launch of Kappa and Lambda RNAscope in situ Hybridization Probes demonstrates a significant advancement in the detection of immunoglobulin mRNA, catering to research and clinical diagnostic communities. This emphasis on product innovation is a strategic move to meet evolving market needs and maintain a competitive edge.

In April 2022, Meridian Bioscience, a prominent US-based life science company, completed the acquisition of Euprotein Inc. This undisclosed transaction is expected to enhance Meridian's recombinant capabilities and expedite the development of novel immunological tools. Euprotein Inc. is a biotechnology company, specializes in the development and manufacturing of bioresearch reagents, aligning with Meridian Bioscience's commitment to advancing the field through strategic acquisitions.

Major companies operating in the biotechnology reagents market are Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation

North America was the largest region in the biotechnology reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biotechnology reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biotechnology reagents market includes revenues earned by entities by chromatography, in-vitro diagnostics, polymerase chain reaction and cell culture technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotechnology reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biotechnology reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biotechnology Reagents Market Characteristics

3. Biotechnology Reagents Market Trends And Strategies

4. Biotechnology Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biotechnology Reagents Growth Analysis And Strategic Analysis Framework

6. Biotechnology Reagents Market Segmentation

7. Biotechnology Reagents Market Regional And Country Analysis

8. Asia-Pacific Biotechnology Reagents Market

9. China Biotechnology Reagents Market

10. India Biotechnology Reagents Market

11. Japan Biotechnology Reagents Market

12. Australia Biotechnology Reagents Market

13. Indonesia Biotechnology Reagents Market

14. South Korea Biotechnology Reagents Market

15. Western Europe Biotechnology Reagents Market

16. UK Biotechnology Reagents Market

17. Germany Biotechnology Reagents Market

18. France Biotechnology Reagents Market

19. Italy Biotechnology Reagents Market

20. Spain Biotechnology Reagents Market

21. Eastern Europe Biotechnology Reagents Market

22. Russia Biotechnology Reagents Market

23. North America Biotechnology Reagents Market

24. USA Biotechnology Reagents Market

25. Canada Biotechnology Reagents Market

26. South America Biotechnology Reagents Market

27. Brazil Biotechnology Reagents Market

28. Middle East Biotechnology Reagents Market

29. Africa Biotechnology Reagents Market

30. Biotechnology Reagents Market Competitive Landscape And Company Profiles

31. Biotechnology Reagents Market Other Major And Innovative Companies

32. Global Biotechnology Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotechnology Reagents Market

34. Recent Developments In The Biotechnology Reagents Market

35. Biotechnology Reagents Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기